Metraipolis › archive › dc_bbb311a996b3
[68Ga]Ga-HER2 Affibody PET/CT for early prediction of neoadjuvant therapy outcome in HER2-positive breast cancer: a preliminary report — Europe PMC PMID:41922613
- Source
- Europe PMC (en)
- Original
- https://europepmc.org/article/MED/41922613
- DOI
- 10.1186/s13550-[numero omesso]-w
- License (as archived)
- solo-consultazione
- Archived
- 2026-11-03T12:15:52.241Z
- SHA-256 of the archived text
b68b9700dca5d7bb2636081a81bce413e4bf474bfe3d9fc1986b689418155ac0- Stable URL of this page
https://metraipolis.com/documento/dc_bbb311a996b3
How to cite
[68Ga]Ga-HER2 Affibody PET/CT for early prediction of neoadjuvant therapy outcome in HER2-positive breast cancer: a preliminary report — Europe PMC PMID:41922613 — Europe PMC (en), https://europepmc.org/article/MED/41922613 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_bbb311a996b3 (Metraipolis archive dc_bbb311a996b3, sha256 b68b9700dca5d7bb2636081a81bce413e4bf474bfe3d9fc1986b689418155ac0)
BibTeX
@misc{dcbbb311a996b3,
title = {[68Ga]Ga-HER2 Affibody PET/CT for early prediction of neoadjuvant therapy outcome in HER2-positive breast cancer: a preliminary report — Europe PMC PMID:41922613},
howpublished = {Europe PMC (en)},
url = {https://europepmc.org/article/MED/41922613},
note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_bbb311a996b3; sha256 b68b9700dca5d7bb2636081a81bce413e4bf474bfe3d9fc1986b689418155ac0},
year = {2026}
}Archived text
The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41922613. Agents can read the archived copy with the MCP tool read_document.